Covid-19 in Hematological Malignancies
Condition(s):COVID-19 Infection in Hematological Malignancies PatientsLast Updated:November 22, 2023Recruiting
Include Studies Not Open or Pending
Condition(s):COVID-19 Infection in Hematological Malignancies PatientsLast Updated:November 22, 2023Recruiting
Condition(s):Infectious Diseases; Hematological MalignanciesLast Updated:December 8, 2020Not yet recruiting
Condition(s):SARS-CoV-2 Infection; Hematological MalignanciesLast Updated:September 23, 2022Recruiting
Condition(s):EBV InfectionLast Updated:February 10, 2021Recruiting
Condition(s):ToxoplasmosisLast Updated:July 27, 2023Not yet recruiting
Condition(s):Hematological Malignancy; NeutropeniaLast Updated:March 12, 2024Recruiting
Condition(s):Multiple Myeloma; Myeloma, Multiple; Myelomas, Multiple; Acute Myeloid Leukemia; Leukemias, Acute Myeloid; Myeloid Leukemias, Acute; Hemophilia; Hemophilia A; Hemophilia As; Hemophilia B; Hemophilia Bs; Myelodysplastic Syndrome; MDS; Lymphoma; Leukemia; Aplastic Anemia; Bleeding Disorder; Bone Marrow Transplantation; Blood Disease InfectionLast Updated:April 25, 2023Recruiting
Condition(s):Invasive AspergillosisLast Updated:October 6, 2023Recruiting
Condition(s):Pseudomonas Aeruginosa; Pneumonia; Hematologic MalignancyLast Updated:August 24, 2023Recruiting
Condition(s):Mycobacterium; Cancer; Treatment Side EffectsLast Updated:February 8, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.